Kentucky Retirement Systems Insurance Trust Fund Grows Position in DaVita Inc. (NYSE:DVA)

Kentucky Retirement Systems Insurance Trust Fund increased its holdings in DaVita Inc. (NYSE:DVA) by 357.7% in the fourth quarter, Holdings Channel reports. The fund owned 6,252 shares of the company’s stock after purchasing an additional 4,886 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in DaVita were worth $935,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Transcendent Capital Group LLC purchased a new stake in DaVita in the third quarter worth about $25,000. Blue Trust Inc. lifted its stake in DaVita by 56.4% in the third quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after acquiring an additional 119 shares during the period. Quarry LP purchased a new stake in DaVita in the third quarter worth about $60,000. Venturi Wealth Management LLC lifted its position in shares of DaVita by 59.8% during the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after buying an additional 152 shares during the last quarter. Finally, Versant Capital Management Inc lifted its position in shares of DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after buying an additional 169 shares during the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

DaVita Stock Performance

DVA opened at $154.98 on Wednesday. DaVita Inc. has a 52-week low of $119.42 and a 52-week high of $179.60. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The company has a market cap of $12.40 billion, a P/E ratio of 14.43, a price-to-earnings-growth ratio of 0.79 and a beta of 0.94. The firm’s 50-day moving average price is $161.41 and its 200-day moving average price is $157.91.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, equities analysts anticipate that DaVita Inc. will post 10.93 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Barclays increased their price target on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $162.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.